Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

[Digoxin-like immunoreactive factors. Review of the literature].

Ozzola G, Boncompagni L, Galastri G, Liberatori E, Marri M, Mazzei V, Patrizi L, Parca G, Piccini L, Biagi P.

Minerva Med. 1995 Nov;86(11):475-80. Review. Italian.

PMID:
8684671
2.

Digoxin-like immunoreactivity, endogenous cardiac glycoside-like factor(s) and natriuretic hormone: more than a hypothesis.

Clerico A.

J Nucl Med Allied Sci. 1987 Oct-Dec;31(4):341-56. Review. No abstract available.

PMID:
2832557
3.

Digoxin-like immunoreactivity: is it still worth measuring?

Goto A, Yamada K, Yagi N, Hui C, Sugimoto T.

Life Sci. 1991;49(23):1667-78. Review.

PMID:
1658518
4.

The pathophysiological role of digitalis-like substance in essential hypertension.

Saitoh S, Shimamoto K, Nakagawa M, Yamaguchi Y, Matsuda K, Kuroda S, Ura N, Iimura O.

J Hypertens Suppl. 1988 Dec;6(4):S360-2.

PMID:
2853746
5.

Variation in apparent serum digitalis-like factor levels with different digoxin antibodies. The "immunochemical fingerprint".

Naomi S, Graves S, Lazarus M, Williams GH, Hollenberg NK.

Am J Hypertens. 1991 Oct;4(10 Pt 1):795-801.

PMID:
1747212
6.
9.

Digoxin-like immunoreactive substance in serum of preterm and full-term neonates.

Bertrand JM, Langhendries JP, Gras A, Battisti O.

Eur J Pediatr. 1987 Mar;146(2):145-6.

PMID:
3032639
10.

Endogenous cardiac glycoside-like substances in newborns, adults, pregnant women and patients with hypertension or renal insufficiency.

Clerico A, Balzan S, Del Chicca MG, Paci A, Cocci F, Bertelli A.

Drugs Exp Clin Res. 1988;14(9):603-7.

PMID:
3229323
11.

Isolation and characterization of a digoxin-like immunoreactive substance from human urine by affinity chromatography.

De Angelis C, Riscazzi M, Salvini R, Piccoli A, Ferri C, Santucci A.

Clin Chem. 1997 Aug;43(8 Pt 1):1416-20.

12.

Influence of assay methodologies and interferences on the interpretation of digoxin concentrations.

Fitzsimmons WE.

Drug Intell Clin Pharm. 1986 Jul-Aug;20(7-8):538-42.

PMID:
3755675
13.

Endogenous digoxin-immunoactive factor in human subjects.

Valdes R Jr.

Fed Proc. 1985 Sep;44(12):2800-5.

PMID:
3839758
14.

Digoxin-like immunoreactive substances in hypertrophic cardiomyopathy.

Mahon N, Mckenna WJ.

Eur Heart J. 2000 Jul;21(13):1034-6. Review. No abstract available.

PMID:
10843817
15.

[Interference of digoxin-like immunoreactive substance in the analysis of digoxin in pulmonary pathology: preliminary results].

Romano L, Zofra S, Imperato G, Adorno V, Maglione A.

Arch Monaldi. 1985 May-Aug;40(3-4):157-64. Italian. No abstract available.

PMID:
3842060
16.

Digoxin-like-immunoreactive substance: non-specific interference or a new hormone?

Clerico A, Ghione S, Balzan S, Del Chicca MG.

J Nucl Med Allied Sci. 1984 Oct-Dec;28(4):297-301. No abstract available.

PMID:
6100187
17.

Ouabain-like factor.

Goto A, Yamada K.

Curr Opin Nephrol Hypertens. 1998 Mar;7(2):189-96. Review.

PMID:
9529622
18.
19.

Endogenous sodium pump inhibition: current status and therapeutic opportunities.

Hollenberg NK, Graves SW.

Prog Drug Res. 1996;46:9-42. Review.

PMID:
8754202
20.

Increased digitalis-like immunoreactive substances in patients with hypertrophic cardiomyopathy.

Hayashi T, Ijiri Y, Toko H, Shimomura H, Okabe M, Terasaki F, Kitaura Y, Kawamura K.

Eur Heart J. 2000 Feb;21(4):296-305.

PMID:
10653677

Supplemental Content

Support Center